PubMed record Goncharova ND, Vengerin AA, Khavinson VK, Lapin BA
therefore, it does not appear to trigger diabetes development or induce glucose intolerance in test models, though further studies are necessary to explore this aspect
Injectable use presents more unknowns
In laboratory research, it is widely studied for its involvement in peptide-regulated signaling, cytoprotective mechanisms, and cellular communication pathways associated with tissue modeling and biological adaptation
Each group was subjected to the following treatments: the same volume of physiological saline solution (Control), TB m A solution (5 mg/kg in physiological saline), or TB m A-Glu (5 mg/kg in physiological saline) was injected through the tail vein of each mouse on 0, 5, and 10 days
SMP provides an effective and lasting solution